GEN Exclusives

More »

GEN News Highlights

More »
Feb 28, 2007

Encorium granted $1.2M Contract for Study

  • Encorium Group received a Phase I trial contract for approximately $1.2 million. This contract is in support of an innovative approach to the development of a vaccine for the prevention of multiple types of influenza, including seasonal and pandemic avian flu.

    Encorium will provide consulting on clinical trial design and protocol development, project and study site management and monitoring, data management, and biostatistical support. Revenue recognition will begin in the first quarter of 2007 on a proportional performance basis over the life of the contract as services are performed.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?